Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Malaria Diagnostics Market: By Technology: Microscopy, Rapid Diagnostics Tests (RDTs), Molecular Diagnostic Tests; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand; Competitive Landscape; Industry Events and Developments
Global Malaria Diagnostics Market Outlook
The global malaria diagnostics market stood at a value of around USD 706.7 million in 2020. The market is further expected to grow at a CAGR of 5.6% in the forecast period of 2022-2027 to attain a value of around USD 980 million by 2026.
Increased Demand for Molecular Diagnostic Tests to Bolster the Market Growth of Malaria Diagnostics
Based on technology, the molecular diagnostic test segment is predicted to account for a substantial market share in the malaria diagnostics industry. This increase can be associated with the high accuracy of these tests in detecting different variants of malaria-causing parasites. These tests are conducted in two ways, namely the polymerase chain reaction (PCR) and quantitative or real time-PCR (qPCR). These tests help detect low parasite counts and mixed infection cases. Moreover, these tests are incredibly sensitive and highly accurate even while detecting low levels of infections. Thus, this segment is estimated to positively catalyse the market growth over the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Middle East and Africa Segment to Occupy a Substantial Market Share in the Global Malaria Diagnostics Industry
The Middle East and Africa is expected to occupy a substantial share of the malaria diagnostics industry in the forecast period. This growth can be attributed to the growing prevalence of malaria in the region caused by the widespread malaria vector, Anopheles gambiae, which is difficult to control. According to the WHO statistics of 2019, the African region alone was home to 94% of all malaria cases and deaths worldwide. Moreover, with the growing geriatric population worldwide, who are more susceptible to such infections, governments, are increasingly investing in the healthcare sector to reduce mortality risks associated with malaria. As a result, malaria diagnostics technology is witnessing a significant demand for the early detection of the disease. These factors are expected to contribute to the industry growth significantly.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Malaria Diagnostics: Industry Definition and Segmentation
Malaria refers to an intermittent and remittent fever caused by a protozoan parasite carried by female Anopheles mosquitoes that invades the red blood cells in the tropical and sub-tropical regions. Patients suffering from malaria often experience fever, chills, and flu-like symptoms. In patients infected by malaria, malaria causing parasite grows and multiplies first in the liver cells and then in the red blood cell. Malaria is usually curable, but it can become life-threatening if not taken care of properly.
Malaria diagnostics refers to the process of identification of the parasite through blood smears under a microscope or through a rapid diagnostic test (RDT).
By technology, the market is divided into:
- Microscopy
- Rapid Diagnostics Tests (RDTs)
- Molecular Diagnostic Tests
Among these, a molecular diagnostic test can be further bifurcated by type into conventional PCR and real time PCR.
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Incidences of Malaria Among Children to Augment the Growth of the Market
According to the WHO statistics of 2019, an estimated 299 million malaria cases were reported in the year, while the total number of deaths caused by malaria stood at 409 thousand in 2019. Out of these, children below five years of age accounted for 67% of all malaria-related deaths worldwide. This is due to the compromised immune system of children due to malnourishment and undernutrition. In addition, children with severe malaria infection also show severe anaemia, respiratory issues concerning metabolic acidosis, or cerebral malaria. Moreover, in the malaria endemic regions, the transmission speed of malaria increases with the longer life span of mosquitoes with a human-biting tendency. For instance, in Africa, the African vector mosquito species have a longer life span and are responsible for the 90% of the world's malaria cases. In this regard, countries worldwide and international organisations are introducing initiatives to control the spread and prevent malaria risks. For instance, the WHO’s Global Malaria Programme and Malaria Consortium's Malaria Prevention and Control Project aim to prevent, protect, and treat children in collaboration with several countries such as Burkina Faso, Cameroon, the Democratic Republic of the Congo, Ghana, Mozambique. Such developments are expected to augment the market growth in the forecast period.
Key Industry Players in the Global Malaria Diagnostics Market
The report gives a detailed analysis of the following key players in the global malaria diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Access Bio Inc.
- Abbott Laboratories
- Premier Medical Corporation Ltd.
- Sysmex Partec GmbH
- bioMérieux SA
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Technology, Region |
| Breakup by Technology | Microscopy, Rapid Diagnostics Tests (RDTs), Molecular Diagnostic Tests |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Trade Data Analysis | Major Importing Countries by Value and Volume, Major Exporting Countries by Value and Volume |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Access Bio, Inc., Abbott Laboratories, Premier Medical Corporation Ltd, Sysmex Partec GmbH, bioMérieux SA, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Malaria Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Malaria Diagnostics Historical Market (2017-2021)
8.3 Global Malaria Diagnostics Market Forecast (2022-2027)
8.4 Global Malaria Diagnostics Market by Technology
8.4.1 Microscopy
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Rapid Diagnostics Tests (RDTs)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Molecular Diagnostic Tests
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.3.4 Breakup by Type
8.4.3.4.1 Conventional PCR
8.4.3.4.1.1 Market Share
8.4.3.4.1.2 Historical Trend (2017-2021)
8.4.3.4.1.3 Forecast Trend (2022-2027)
8.4.3.4.2 Real-Time PCR
8.4.3.4.2.1 Market Share
8.4.3.4.2.2 Historical Trend (2017-2021)
8.4.3.4.2.3 Forecast Trend (2022-2027)
8.5 Global Malaria Diagnostics Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Access Bio Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Abbott Laboratories
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Premier Medical Corporation Private Limited
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Sysmex Corporation
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 bioMérieux SA
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Malaria Diagnostics Market: Key Industry Highlights, 2017 and 2027
2. Global Malaria Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2021
3. Global Malaria Diagnostics Market Forecast: Breakup by Technology (USD Million), 2022-2027
4. Global Malaria Diagnostics Historical Market: Breakup by Region (USD Million), 2017-2021
5. Global Malaria Diagnostics Market Forecast: Breakup by Region (USD Million), 2022-2027
6. North America Malaria Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
7. North America Malaria Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
8. Europe Malaria Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
9. Europe Malaria Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Asia Pacific Malaria Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11. Asia Pacific Malaria Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Latin America Malaria Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
13. Latin America Malaria Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Middle East and Africa Malaria Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
15. Middle East and Africa Malaria Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Global Malaria Diagnostics Market Structure
Key Questions Answered in the Report
In 2020, the global malaria diagnostics market attained a value of nearly USD 706.7 million.
The market is projected to grow at a CAGR of 5.6% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 980 million by 2026.
The major drivers of the industry, such as the increased mortality risks of malaria among children below 5 years, growing geriatric population susceptible to malaria and its subsequent diseases, heightened demand for malaria diagnosis in malaria endemic regions, and the rapid investments being made by the governments and key market players in the manufacturing of medicines due to the rising issues of drug resistance, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the increased investments in the research and development of malaria detection and treatment by international health organisations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant technologies of malaria diagnostics in the market are microscopy, rapid diagnostics tests (RDTs), and molecular diagnostic test. Among these, molecular diagnostic test can be further bifurcated by type into conventional PCR and real time PCR.
The major players in the industry are Access Bio Inc, Abbott Laboratories, Premier Medical Corporation Ltd., Sysmex Partec GmbH, and bioMérieux SA among others.
Analyst Review
The global malaria diagnostics market attained a value of nearly USD 706.7 million in 2020, driven by the growing incidences of malaria globally. Aided by the rapid clinical advancements in the diagnostic technology, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5.6%. The market is projected to reach about USD 980 million by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of technology, the market can be segmented into drugs, vaccines and oxygen therapy. Among these, drugs can be further divided by type into microscopy, rapid diagnostics tests (RDTs), and molecular diagnostic test. The major regional markets for malaria diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Access Bio Inc, Abbott Laboratories, Premier Medical Corporation Ltd., Sysmex Partec GmbH, bioMérieux SA, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global RSV diagnostics market attained a value of about USD 846.96 million in 2021, driven by the rising prevalence of RSV disorders. Aided by large scale investment into the healthcare sector, th...
The global veterinary diagnostic imaging market is driven by the growing prevalence of health-related issues in animals. Aided by the increasing use of veterinary diagnostic imaging in research activi...
The global urinalysis market attained a value of about USD 1.9 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 6.8% to reach nearly USD 2.8 bil...
The global dengue testing market attained a value of USD 456.2 million in 2020, driven by the rise in the number of dengue cases. Aided by increasing research and development related activities to dev...
The global clinical nutrition market attained a value of about USD 33.60 billion in 2020, driven by the rise in the prevalence of metabolic disorders. Aided by the high spending on healthcare and incr...
NEWSLETTER